Upcoming GB active substance renewal submission deadlines
Apply for active substance renewal by the relevant deadlines to keep products on the GB market.
Under the GB Biocidal Products Regulation (GB BPR), active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date.
The 550-day deadlines are coming up for the following active substance/product type combinations under GB BPR:
29 March 2026
- peracetic acid (CAS 79-21-0 EC 201-186-8) in product types 1, 2, 3, 4, 5 and 6
29 June 2026
- 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB) (CAS 35691-65-7 EC 252-681-0) in product type 6
- amines, N-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid (ampholyt 20) (CAS 139734-65-9 EC 701-317-3) in product types 2, 3 and 4
- Bacillus amyloliquefaciens strain ISB06 (CAS N/A EC N/A) in product type 3
- biphenyl-2-ol (CAS 90-43-7 EC 201-993-5) in product type 3
28 December 2026
- 2-methyl-1,2-benzothiazol-3(2H)-one (MBIT) (CAS 2527-66-4 EC 695-989-4) in product type 6
30 June 2027
- active chlorine released from calcium hypochlorite (CAS 7778-54-3 EC 231-908-7) in product types 2, 3, 4 and 5
- active chlorine released from chlorine (CAS 7782-50-5 EC 231-959-5) in product types 2 and 5
- active chlorine released from sodium hypochlorite (CAS 7681-52-9 EC 231-668-3) in product types 1, 2, 3, 4 and 5
- peracetic acid generated from tetra-acetylethylenediamine (TAED) and sodium percarbonate (CAS 79-21-0 EC N/A) in product types 2, 3 and 4
Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.
Check the GB Article 95 List to see who the original supporters were.
If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know.
If a renewal application is not submitted for the above active substance/product type combinations under GB BPR, the approvals will expire. This means the active substances will no longer be able to be used in biocidal products of the relevant product types in GB.
In addition, articles treated with such products will no longer be able to be placed on the market in GB.
